Table 3

Peak CSF and corresponding serum values (pg/ml) of immune mediators in animals that were inoculated with B. burgdorferi.

MEDIATOR
DR50
EL81
EP51
DH50
CH82

IL-6
(wk-1)
(wk-1)
(wk-1)
(wk-1)
(wk-1)
CSF
17.8 ± 0.4
10 ± 0.9
3.7 ± 0.5
46.9 ± 0.2
2.9 ± 0.7
SERUM
0.7 ± 0.2
0.3 ± 0.05
1 ± 0.2
0
3.9 ± 0.5

IL-8
(wk-1)
(wk-2)
(wk-2)
(wk-1)
(wk-2)
CSF
33.4 ± 4.2
15.7 ± 0.1
21.9 ± 1.0
34.5 ± 0.9
10.9 ± 2.0
SERUM
832.8 ± 75
697.6 ± 86.2
625.6 ± 3.7
3442 ± 149.2
422.4 ± 25

CCL2/MCP-1
(wk-2)
(wk 2)
(wk-3)
(wk-3)

CSF
475.9 ± 25.2
345.6 ± 62.3
404.5 ± 6.8
442.3 ± 6.8
*
SERUM
114.1 ± 6.5
71.8 ± 0.4
106.2 ± 2.8
39 ± 11.2


CXCL13/BLC
(wk-3)
(wk-2)
(wk-4)
(wk-3)

CSF
5500
811.5
779
5317.8 ± 70.5
*
SERUM
300
748
1221
199


The time points at which peak values of various immune mediators (pg/ml) were observed in the CSF and corresponding values found in the serum of B. burgdorferi-infected animals are shown. Data represent the mean ± SD of duplicate determinations, except for CXCL13 in animals DR50, EL81, and EP51, where remaining CSF volume available only permitted a single determination.

* CSF concentrations of CCL2 and CXCL13 for animal CH82 were not significantly elevated with respect to control animals.

Ramesh et al. Journal of Neuroinflammation 2009 6:23   doi:10.1186/1742-2094-6-23

Open Data